rs730880899
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP2PP3_ModeratePP5
The NM_000257.4(MYH7):c.2544G>C(p.Glu848Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E848G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.2544G>C | p.Glu848Asp | missense_variant | 22/40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.2544G>C | p.Glu848Asp | missense_variant | 21/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.2544G>C | p.Glu848Asp | missense_variant | 22/40 | 1 | NM_000257.4 | ENSP00000347507.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 14, 2015 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Glu848Asp in MYH7 has not been previously reported in individuals with cardiomyopathy or in large population studies. The glutamate residue (Glu) at position 848 is high ly conserved in mammals and across evolutionarily distant species, and the chang e to aspartic acid (Asp) was predicted to be pathogenic using a computational to ol clinically validated by our laboratory. This tool's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011). In summary, while there i s some suspicion for a pathogenic role, the clinical significance of the p.Glu84 8Asp variant is uncertain. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 05, 2016 | A variant of uncertain significance has been identified in the MYH7 gene. The E848D variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. However, this variant has previously been observed in other unrelated individuals referred for cardiomyopathy genetic testing at GeneDx, but segregation data is absent. In addition, this variant has been classified in ClinVar as a variant of uncertain significance by other clinical laboratories (ClinVar SCV000272040.1, SCV000280327.1; Landrum et al., 2016). The E848D variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position that is conserved across species and 2/3 in silico prediction programs predict this variant is probably damaging to the protein structure/function. However, the E848D variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Furthermore, to our knowledge no studies have been performed to determine the functional effect of the E848D variant.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or benign. - |
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Nov 29, 2014 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Glu848Asp (c.2544G>C) in MYH7 This is a conservative amino acid substitution with a hydrophilic Glutamine replaced with a hydrophilic Asparagine. Conservation analysis indicates that Glutamine is highly conserved at this position and in silico algorithms (Adzhubei et al 2010) predict the amino acid change to be probably damaging to protein structure/function. Missense variants in nearby codons (Lys847Glu, Ala850Asp, and Ala850Thr) have been reported in association with cardiomyopathy thus indicating a functional significance of this region of beta myosin heavy chain protein. In total p.Glu848Asp has not been observed in ~5500 individuals of varying ancestry. GeneDx reports the absence of the variant in 200 presumably healthy controls of both Caucasian and African American ancestry. The variant is not currently listed in NHLBI Exome Sequencing Project dataset (http://evs.gs.washington.edu/EVS/). This dataset includes variant calls on approximately ~5300 well phenotyped individuals of Caucasian and African American descent (as of January 2012). The variant is not reported in dbSNP or 1000 Genomes (As of January 2012). - |
Hypertrophic cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 29, 2022 | This variant is not present in population databases (gnomAD no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Glu848 amino acid residue in MYH7. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function. ClinVar contains an entry for this variant (Variation ID: 181374). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 30847666, 33673806). This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 848 of the MYH7 protein (p.Glu848Asp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at